Close Menu

NEW YORK – Genomic sequencing firm Personalis reported after the close of the market on Wednesday that its third quarter revenues were up 47 percent year over year, driven by a single sequencing contract.

In its second earnings report after going public in June, the company said it recorded total revenues of $17.2 million compared to $11.7 million in Q3 2018, beating Wall Street analysts' consensus estimate of $15.8 million.

According to Personalis, its ongoing contract with the US Department of Veterans Affairs was the main driver for this quarterly growth.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A German shepherd called Nala has had her genome sequenced.

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.